Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across biomedical AI, cancer, cardiovascular diseases, immunity, age-related, rare and infectious diseases.

          Learn more

        • Biomedical AI
        • Cancer Innovations
        • Cardiovascular Research
        • Infection & Immunity
        • Rare Diseases & Gene Therapy
        • Laboratories
        • Impact
        • Technologies
        • Commercialisation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research.

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your will
        • Donate in memory
        • Advise on our research
  • Careers & students
        • Careers & Students

          Postdoctoral and postgraduate students can work alongside world-leading medical researchers within state-of-the-art research facilities.

        • Careers
        • Study opportunities
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events.

        • News
        • Statements
        • Events
        • Real stories
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges.

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Animals in research
        • Contact
  • Donate
    Centenary Institute > News > Blood fats predict success of dietary weight loss in pre-diabetes management

Blood fats predict success of dietary weight loss in pre-diabetes management

Date time 3 September, 2024
News Type News type Media release
New research from the Centenary Institute has identified specific blood fats that can predict how effectively individuals with pre-diabetes will improve their blood sugar levels through diet and weight loss. These findings could pave the way for more personalised approaches to preventing and managing type 2 diabetes.

Pre-diabetes is a condition where blood sugar levels are higher than normal but not yet in the diabetic range. Weight loss through dieting is a common recommendation to help bring blood sugar levels back to normal. However, more than half of people with pre-diabetes do not achieve normal blood sugar levels after losing weight.

This new study, based on samples from 104 participants, aimed to identify biomarkers in the blood that could predict who would benefit most from dietary weight loss. The participants, all with pre-diabetes, lost at least 8% of their body weight through a low-energy diet. Using big data technology and machine learning based bioinformatics, researchers then analysed changes in hundreds of different lipids­­—molecules in the blood that include fats and fatty acids—before and after the diet.

Published in The American Journal of Clinical Nutrition, the study found that weight loss led to significant changes in several types of lipids. Importantly, certain lipids measured before the weight loss could predict how much participants’ blood sugar levels would improve afterward. For example, certain sphingolipids, a type of fat found in cell membranes, were linked to changes in fasting blood sugar levels, while other lipids were associated with improvements in indicators such as hemoglobin A1c, insulin and insulin resistance.

“Our findings reveal that certain fats in the blood can tell us a lot about a person’s chances of improving their blood sugar levels through weight loss,” said lead study author, Dr Yanfei (Jacob) Qi from the Centenary Institute’s Centre for Cardiovascular Research.

“This could be a game-changer in how we approach diabetes prevention, allowing us to personalise treatment plans for those who are less likely to benefit from standard diet recommendations,” he said.

The researchers believe that discovering these lipid biomarkers offers hope for more effective diabetes prevention strategies and better outcomes for those at risk, moving beyond the one-size-fits-all advice currently offered.

Next, Dr Qi and his team will assess the power of lipid predictors in a more challenging real-world scenario—a three-year lifestyle intervention through both diet and physical activity for weight control in individuals with pre-diabetes.

Publication: Deep serum lipidomics identifies evaluative and predictive biomarkers for individualized glycemic responses following low-energy diet-induced weight loss: a PREVIEW sub-study.

Themes

  • Cardiovascular Research

    Cardiovascular Research

Media enquires

For all media and interview enquiries, please contact Tony Crawshaw

Phone number Phone Number +61 402 770 403

Email Email t.crawshaw@centenary.org.au

Media Release

Blood fats predict success of dietary weight loss in pre-diabetes management

Download

Recent Stories

  • New grant targets longer-lasting islet cell treatments for type 1 diabetes

    Dr Lise Hunault, a researcher in the Centenary Institute’s Centre for Biomedical AI, has been awarded a major research grant from Breakthrough T1D, the leading global type 1 diabetes research and advocacy organisation, to advance islet-cell replacement therapies for type 1 diabetes.
    News Type: Research News
    Date 16 Mar 2026
  • Centenary marks International Women’s Day with inspiring speakers

    The Centenary Institute community came together to celebrate International Women’s Day 2026, with a special event highlighting this year’s Australian theme, ‘Balancing the Scales.’
    News Type: Community
    Date 11 Mar 2026
  • Vaxosome launched to develop next-generation mRNA vaccines

    A new biotechnology company, Vaxosome, has been launched to develop next-generation vaccines aimed at tackling some of the world’s most challenging infectious diseases.
    News Type: Research News
    Date 10 Mar 2026
  • Centenary partners in transformative national liver health program

    The Snow Medical Research Foundation has today announced major long-term funding of $15.5 million for a new national research program targeting fatty liver disease, a condition that affects up to one in three Australians. The Centenary Institute will play a key role in the collaborative effort.
    News Type: Research News
    Date 05 Mar 2026

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About us
  • Governance
  • Corporate information

Research

  • Our researchers
  • News

Careers & studies

  • Career opportunities
  • Student opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement
  • Staff Intranet

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Contact Privacy

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram